Use of Johnson & Johnson vaccine resumes after study

Use of the Johnson & Johnson vaccine will resume at Gundersen Health System, based on CDC and FDA guidance. Available data suggest the risk of blood clots is very low, but the CDC and FDA will closely monitor this risk. Read the full CDC and FDA guidance.

Our patients should know:

The benefits of getting the COVID-19 vaccine – avoiding hospitalization and death – far outweigh the very low risk of complications associated with the vaccine.

Gundersen will continue providing Johnson & Johnson vaccine as it receives doses from state suppliers.

Johnson & Johnson is a safe, effective vaccine option, confirmed by the CDC and FDA.

The risk of blood clots and other severe reactions from any COVID-19 vaccine is about as rare as being struck by lightning.

Gundersen provided 1,227 Johnson & Johnson doses to patients across our system before pausing to allow CDC and FDA vaccine study.

The single-dose Johnson & Johnson vaccine has been a safe, popular option for people who receive the vaccine from Gundersen.

Vaccination appointments at Gundersen are open to anyone age 16 or older through MyChart or by calling scheduling line at (608) 775-6829. (Reminder: Pfizer is the only vaccine currently approved for people ages 16 and 17.)

Treatment for severe reactions:

A sore arm, mild joint pain or fever are normal signs your body is building protection after you get the COVID-19 vaccine.

Call 911 if your leg or arm begins to cramp, swell or becomes warm to the touch; if you experience a severe headache; or if you experience shortness of breath after you get the COVID-19 vaccine. Learn more about COVID-19 vaccine and rare severe allergic reactions.